
    
      The objectives of the study is as following;

        -  Validation of the previously defined In-Vitro Activation Protocol approach in Turkish
           patients under 36 years old with Premature Ovarian Insufficiency (POI).

        -  Giving an opportunity to young POI patient in Turkey for having genetically own baby.

        -  Primary outcome measure would be live birth.

        -  For activation of primordial follicles, phosphatase and tensin homolog (PTEN) inhibitor
           and protein kinase B (AKT) stimulator will be used.
    
  